Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PORTER AT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 90 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Porter, AT; Ben-Josef, E
      Humoral mechanisms in prostate cancer: A role for FSH

      UROLOGIC ONCOLOGY
    2. Porter, AT
      Painful osteoblastic metastases: The role of nuclear medicine - The Silberstein article reviewed

      ONCOLOGY-NEW YORK
    3. Ben-Josef, E; Porter, AT; Han, S; Mertens, W; Chuba, P; Fontana, J; Hussain, M
      Neoadjuvant estramustine and etoposide followed by concurrent estramustineand definitive radiotherapy for locally advanced prostate cancer: Feasibility and preliminary results

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    4. Gospodarowicz, MK; Milosevic, MF; Warde, P; Porter, AT
      Clinical situations for the role of radiation therapy in the treatment of bladder cancer

      BLADDER CANCER: CURRENT DIAGNOSIS AND TREATMENT
    5. Hart, KB; Wood, DP; Tekyi-Mensah, S; Porter, AT; Pontes, JE; Forman, JD
      The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    6. Ben-Josef, E; Shamsa, F; Youssef, E; Porter, AT
      External beam radiotherapy for painful osseous metastases: Pooled data dose response analysis

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    7. Garde, SV; Basrur, VS; Li, L; Finkelman, MA; Krishan, A; Wellham, L; Ben-Josef, E; Haddad, M; Taylor, JD; Porter, AT; Tang, DG
      Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis

      PROSTATE
    8. Li, L; Zhu, ZY; Joshi, B; Porter, AT; Tang, DG
      A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies

      ANTICANCER RESEARCH
    9. Li, L; Zhu, ZY; Joshi, B; Zhang, C; Johnson, CR; Marnett, LJ; Honn, KV; Crissman, JD; Porter, AT; Tang, DG
      A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies

      ANTICANCER RESEARCH
    10. Maughan, RL; Brambs, B; Porter, AT; Forman, JD
      The cost-effectiveness of mixed beam neutron-photon radiation therapy in the treatment of adenocarcinoma of the prostate

      STRAHLENTHERAPIE UND ONKOLOGIE
    11. Maughan, RL; Chuba, P; Porter, AT; Ben-Josef, E; Lucas, DR; Bjarngard, BE
      Mass energy-absorption coefficients and mass collision stopping powers forelectrons in tumors of various histologies

      MEDICAL PHYSICS
    12. Ben-Josef, E; Yang, SY; Ji, TH; Bidart, JM; Garde, SV; Chopra, DP; Porter, AT; Tang, DG
      Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)

      JOURNAL OF UROLOGY
    13. Joshi, B; Li, L; Taffe, BG; Zhu, ZY; Wahl, S; Tian, H; Ben-Josef, E; Taylor, JD; Porter, AT; Tang, DG
      Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain

      CANCER RESEARCH
    14. Porter, AT; Hart, KB
      Radiation therapy in the treatment of localized/organ-confined prostate cancer

      TEXTBOOK OF PROSTATE CANCER
    15. Roach, M; Porter, AT
      Neoadjuvant hormonal radiotherapy for prostate cancer: Status and controversies

      MOLECULAR UROLOGY
    16. Fair, WR; Porter, AT; Roach, M
      Neoadjuvant hormonal radiotherapy for prostate cancer: Status and controversies - Discussion

      MOLECULAR UROLOGY
    17. HART KB; HAN I; SHAMSA F; COURT WS; CHUBA P; DEPPE G; MALONE J; CHRISTENSEN C; PORTER AT
      RADIATION-THERAPY FOR ENDOMETRIAL CANCER IN PATIENTS TREATED FOR POSTOPERATIVE RECURRENCE

      International journal of radiation oncology, biology, physics
    18. BENJOSEF E; SHAMSA F; WILLIAMS AO; PORTER AT
      RADIOTHERAPEUTIC MANAGEMENT OF OSSEOUS METASTASES - A SURVEY OF CURRENT PATTERNS OF CARE

      International journal of radiation oncology, biology, physics
    19. CHAMBERLAIN RM; WINTER KA; VIJAYAKUMAR S; PORTER AT; ROACH M; STREETER O; COX JD; BONDY ML
      SOCIODEMOGRAPHIC ANALYSIS OF PATIENTS IN RADIATION-THERAPY ONCOLOGY GROUP CLINICAL-TRIALS

      International journal of radiation oncology, biology, physics
    20. TRIKHA M; RASO E; CAI YL; FAZAKAS Z; PAKU S; PORTER AT; TIMAR J; HONN KV
      ROLE OF ALPHA-IIB-BETA-3 INTEGRIN IN PROSTATE-CANCER METASTASIS

      The Prostate
    21. GARG MK; TEKYIMENSAH S; BOLTON S; VELASCO J; PONTES E; WOOD DP; PORTER AT; FORMAN JD
      IMPACT OF POSTPROSTATECTOMY PROSTATE-SPECIFIC ANTIGEN NADIR ON OUTCOMES FOLLOWING SALVAGE RADIOTHERAPY

      Urology
    22. BENJOSEF E; SHAMSA F; YOUSSEF E; PORTER AT
      EXTERNAL-BEAM RADIOTHERAPY FOR PAINFUL OSSEOUS METASTASES - POOLED DATA DOSE-RESPONSE ANALYSIS

      Radiology
    23. TANG DG; LI L; CHOPRA DP; PORTER AT
      EXTENDED SURVIVABILITY OF PROSTATE-CANCER CELLS IN THE ABSENCE OF TROPHIC FACTORS - INCREASED PROLIFERATION, EVASION OF APOPTOSIS, AND THE ROLE OF APOPTOSIS PROTEINS

      Cancer research
    24. MERTENS WC; FILIPCZAK LA; BENJOSEF E; DAVIS LP; PORTER AT
      SYSTEMIC BONE-SEEKING RADIONUCLIDES FOR PALLIATION OF PAINFUL OSSEOUSMETASTASES - CURRENT CONCEPTS

      Ca
    25. BIALKOWSKI MM; WIERZBICKI JG; PORTER AT
      MODELING OF INTERNAL DOSE DISTRIBUTIONS DURING SR-89 TREATMENT OF A PATIENT WITH BONE METASTASES

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    26. BENJOSEF E; CHUBA P; FONTANESSI J; RYAN JR; PORTER AT
      BRACHYTHERAPY IMPROVES OUTCOME OF RADIOTHERAPY FOR SOFT-TISSUE SARCOMA OF THE EXTREMITIES

      European journal of cancer
    27. BENJOSEF E; PORTER AT
      RADIOISOTOPES IN THE TREATMENT OF BONE METASTASES

      Annals of medicine
    28. BENJOSEF E; CHUBA P; FONTANESI J; ZALUPSKI M; RYAN JR; FILIPZACK L; PORTER AT
      RADIOTHERAPY AS A SURGICAL ADJUNCT IN SOFT-TISSUE SARCOMA OF THE RETROPERITONEUM, PELVIS, AND TRUNK

      International journal of radiation oncology, biology, physics
    29. TANG DG; PORTER AT
      TARGET TO APOPTOSIS - A HOPEFUL WEAPON FOR PROSTATE-CANCER

      The Prostate
    30. GAO X; PORTER AT; GRIGNON DJ; PONTES JE; HONN KV
      DIAGNOSTIC AND PROGNOSTIC MARKERS FOR HUMAN PROSTATE-CANCER

      The Prostate
    31. CHUBA PJ; FORMAN JD; BENJOSEF E; HART KH; PORTER AT
      CLINICAL STRATEGIES FOR IMPROVING THE RADIOTHERAPEUTIC MANAGEMENT OF PROSTATE-CANCER

      Anticancer research
    32. MAUGHAN RL; CHUBA PJ; PORTER AT; BENJOSEF E; LUCAS DR
      THE ELEMENTAL COMPOSITION OF TUMORS - KERMA DATA FOR NEUTRONS

      Medical physics
    33. HART KB; PORTER AT
      A RATIONAL APPROACH TO THE TREATMENT OF PROSTATE-CANCER WITH RADIATION-THERAPY - LESSONS FOR THE FUTURE

      Seminars in oncology
    34. FORMAN JD; MEETZE K; PONTES E; WOOD DP; SHAMSA F; RANA T; PORTER AT
      THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POSTPROSTATECTOMY PROSTATE-SPECIFIC ANTIGEN LEVEL

      The Journal of urology
    35. FORMAN JD; MEETZE K; PONTES E; WOOD DP; SHAMSA F; RANA T; PORTER AT
      THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POSTPROSTATECTOMY PROSTATE-SPECIFIC ANTIGEN LEVEL - REPLY

      The Journal of urology
    36. TANG DG; GUAN KL; LI L; HONN KV; CHEN YQ; RICE RL; TAYLOR JD; PORTER AT
      SUPPRESSION OF W256 CARCINOSARCOMA CELL APOPTOSIS BY ARACHIDONIC-ACIDAND OTHER POLYUNSATURATED FATTY-ACIDS

      International journal of cancer
    37. CHEN YQ; TRIKHA M; GAO XA; BAZAZ R; PORTER AT; TIMAR J; HONN KV
      ECTOPIC EXPRESSION OF PLATELET INTEGRIN ALPHA-IIB-BETA-3 IN TUMOR-CELLS FROM VARIOUS SPECIES AND HISTOLOGICAL ORIGIN

      International journal of cancer
    38. TRIKHA M; TIMAR J; LUNDY SK; SZEKERES K; CAI YL; PORTER AT; HONN KV
      THE HIGH-AFFINITY ALPHA-IIB-BETA-3 INTEGRIN IS INVOLVED IN INVASION OF HUMAN-MELANOMA CELLS

      Cancer research
    39. CHUBA PJ; ARONIN P; BHAMBHANI K; EICHHORN M; ZAMARANO L; CIANCI P; MUHLBAUER M; PORTER AT; FONTANESI J
      HYPERBARIC-OXYGEN THERAPY FOR RADIATION-INDUCED BRAIN INJURY IN CHILDREN

      Cancer
    40. CHUBA PJ; PORTER AT; BENJOSEF E; HART K; FORMAN JD
      CURATIVE TREATMENT OF PROSTATE-CANCER WITH THE COMBINATION OF RADIATION AND HORMONE THERAPIES

      Endocrine-related cancer
    41. FORMAN JD; DUCLOS M; SHAMSA F; PORTER AT; ORTON C
      HYPERFRACTIONATED CONFORMAL RADIOTHERAPY IN LOCALLY ADVANCED PROSTATE-CANCER - RESULTS OF A DOSE-ESCALATION STUDY

      International journal of radiation oncology, biology, physics
    42. PORTER AT; ZIMMERMAN J; RUFFIN M; CHERNEW M; CALLAGHAN C; DAVIS R; LEE F; MONTIE J; SWANSON GM; OESTERLING JE
      RECOMMENDATIONS OF THE FIRST MICHIGAN CONFERENCE ON PROSTATE-CANCER

      Urology
    43. TRIKHA M; TIMAR J; LUNDY SK; SZEKERES K; TANG KQ; GRIGNON D; PORTER AT; HONN KV
      HUMAN PROSTATE CARCINOMA-CELLS EXPRESS FUNCTIONAL ALPHA-IIB-BETA-3 INTEGRIN

      Cancer research
    44. GAO X; ZACHAREK A; GRIGNON D; LIU H; SAKR W; PORTER AT; CHEN YQ; HONN KV
      HIGH-FREQUENCY OF LOSS OF EXPRESSION AND ALLELIC DELETION OF THE APC AND MCC GENES IN HUMAN PROSTATE-CANCER

      International journal of oncology
    45. GAO X; ZACHAREK A; GRIGNON DJ; SAKR W; POWELL IJ; PORTER AT; HONN KV
      LOCALIZATION OF POTENTIAL TUMOR-SUPPRESSOR LOCI TO A LESS-THAN-2 MB REGION ON CHROMOSOME 17Q IN HUMAN PROSTATE-CANCER

      Oncogene
    46. GAO X; CHEN YQ; WU N; GRIGNON DJ; SAKR W; PORTER AT; HONN KV
      SOMATIC MUTATIONS OF THE WAF1 CIP1 GENE IN PRIMARY PROSTATE-CANCER/

      Oncogene
    47. FORMAN JD; KUMAR R; HAAS G; MONTIE J; PORTER AT; MESINA CF
      NEOADJUVANT HORMONAL DOWNSIZING OF LOCALIZED CARCINOMA OF THE PROSTATE - EFFECTS ON THE VOLUME OF NORMAL TISSUE IRRADIATION

      Cancer investigation
    48. FORMAN JD; WARMELINK C; DEVI S; COURT W; SHARMA R; YUDELEV M; PORTER AT; MAUGHAN R
      ALTERNATING CONFORMAL NEUTRON AND PHOTON IRRADIATION FOR LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE

      American journal of clinical oncology
    49. BENJOSEF E; MAUGHAN RL; VASAN S; PORTER AT
      A DIRECT MEASUREMENT OF SR-89 ACTIVITY IN BONE METASTASES

      Nuclear medicine communications
    50. BENJOSEF E; LUCAS DR; VASAN S; PORTER AT
      SELECTIVE ACCUMULATION OF SR-89 IN METASTATIC DEPOSITS IN BONE - RADIO-HISTOLOGICAL CORRELATION

      Nuclear medicine communications
    51. GAO X; GRIGNON DJ; CHBIHI T; ZACHAREK A; CHEN YQ; SAKR W; PORTER AT; CRISSMAN JD; PONTES JE; POWELL IJ; HONN KV
      ELEVATED 12-LIPOXYGENASE MESSENGER-RNA EXPRESSION CORRELATES WITH ADVANCED-STAGE AND POOR DIFFERENTIATION OF HUMAN PROSTATE-CANCER

      Urology
    52. BENJOSEF E; MESINA J; SHAW LM; BONNER HS; SHAMSA F; PORTER AT
      TOPICAL APPLICATION OF WR-2721 ACHIEVES HIGH-CONCENTRATIONS IN THE RECTAL WALL

      Radiation research
    53. LUCAS DR; BENJOSEPH E; VASAN S; PORTER AT
      SELECTIVE ACCUMULATION OF SR-89 IN METASTATIC DEPOSITS IN BONE - RADIO-HISTOLOGIC CORRELATION

      Laboratory investigation
    54. GAO X; ZACHAREK A; SALKOWSKI A; GRIGNON DJ; SAKR W; PORTER AT; HONN KV
      LOSS OF HETEROZYGOSITY OF THE BRCA1 AND OTHER LOCI ON CHROMOSOME 17Q IN HUMAN PROSTATE-CANCER

      Cancer research
    55. PORTER AT; BLASKO JC; GRIMM PD; REDDY SM; RAGDE H
      BRACHYTHERAPY FOR PROSTATE-CANCER

      Ca
    56. SEVERSON RK; MONTIE JE; PORTER AT; DEMERS RY
      RECENT TRENDS IN INCIDENCE AND TREATMENT OF PROSTATE-CANCER AMONG ELDERLY MEN

      Journal of the National Cancer Institute
    57. FELDMEIER JJ; HEIMBACH RD; DAVOLT DA; BRAKORA MJ; SHEFFIELD PJ; PORTER AT
      DOES HYPERBARIC-OXYGEN HAVE A CANCER-CAUSING OR CANCER-PROMOTING EFFECT - A REVIEW OF THE PERTINENT LITERATURE

      Undersea & hyperbaric medicine
    58. GAO XA; WU N; GRIGNON D; ZACHAREK A; LIU H; SALKOWSKI A; LI GY; SAKR W; SARKAR F; PORTER AT; CHEN YQ; HONN KV
      HIGH-FREQUENCY OF MUTATOR PHENOTYPE IN HUMAN PROSTATIC ADENOCARCINOMA

      Oncogene
    59. CIANFIONE D; PONTI S; BONELLI F; PONTI A; PORTER AT; CREA F; MASERI A
      MEASUREMENT OF LEFT-VENTRICULAR EJECTION FRACTION BY ARTIFICIAL VISION-NEURAL NETWORK

      Journal of the American College of Cardiology
    60. PONTI A; LANZA GA; PONTI S; PORTER AT; RAISWELL H; CREA F; MASERI A; CIANFLONE D
      STANDALONE C-LANGUAGE BASED PROGRAM FOR SINGLE AND MEAN COSINOR ANALYSIS OF TIME-SERIES

      Journal of the American College of Cardiology
    61. RAISWELL H; PRAGLIOLA C; MARTINELLI L; PORTER AT; PONTI A; PONTI S; CREA F; POSSATI G; CIANFLONE D
      A GRAPHICAL INTERFACE DATABASE FOR STEP-BY-STEP COLLECTION OF DATA DURING CARDIAC-SURGERY

      Journal of the American College of Cardiology
    62. MARUYAMA Y; EZZELL G; PORTER AT
      AFTERLOADING HIGH-DOSE-RATE INTRACAVITARY VAGINAL CYLINDER

      International journal of radiation oncology, biology, physics
    63. PORTER AT; FONTANESI J
      PALLIATIVE IRRADIATION FOR BONE METASTASIS - A NEW PARADIGM

      International journal of radiation oncology, biology, physics
    64. GARDE SV; SHETH AR; VENKATESAN VM; PANCHAL CJ; PORTER AT; GRIGNON DJ
      PROSTATE INHIBIN PEPTIDE (PIP) IN PROSTATE-CANCER - A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY WITH PROSTATE-SPECIFIC ANTIGEN (PSA) AND PROSTATIC ACID-PHOSPHATASE (PAP)

      Cancer letters
    65. PORTER AT
      SR-89 (METASTRON) IN THE TREATMENT OF PROSTATE-CANCER METASTATIC TO BONE

      European urology
    66. MCEWAN AJB; AMYOTTE GA; MCGOWAN DG; MACGILLIVRAY JA; PORTER AT
      A RETROSPECTIVE ANALYSIS OF THE COST-EFFECTIVENESS OF TREATMENT WITH METASTRON IN PATIENTS WITH PROSTATE-CANCER METASTATIC TO BONE

      European urology
    67. PORTER AT; RESCHE
      RADIOPHARMACEUTICALS IN PROSTATE-CANCER - PROGRESS IN THE TREATMENT OF PAINFUL BONY METASTASES - DISCUSSION

      European urology
    68. MCEWAN AJB; AMYOTTE GA; MCGOWAN DG; MACGILLIVRAY JA; PORTER AT
      A RETROSPECTIVE ANALYSIS OF THE COST-EFFECTIVENESS OF TREATMENT WITH METASTRON(R) (SR-89-CHLORIDE) IN PATIENTS WITH PROSTATE-CANCER METASTATIC TO BONE

      Nuclear medicine communications
    69. WIERZBICKI JG; MARUYAMA Y; PORTER AT
      MEASUREMENT OF AUGMENTATION OF CF-252 IMPLANT BY B-10 AND GD-157 NEUTRON-CAPTURE

      Medical physics
    70. PORTER AT; FORMAN JD
      THE ROLE OF RADIOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED PROSTATE-CANCER

      Urology
    71. PORTER AT; VAISHAMPAYAN N
      SR-89 IN METASTATIC PROSTATE-CANCER

      Urology
    72. CRAWFORD ED; KOZLOWSKI JM; DEBRUYNE FMJ; FAIR WR; LOGOTHETIS CJ; BALMER C; ROBINSON RG; PORTER AT; KIRK D
      THE USE OF STRONTIUM-89 FOR PALLIATION OF PAIN FROM BONE METASTASES ASSOCIATED WITH HORMONE-REFRACTORY PROSTATE-CANCER

      Urology
    73. MARUYAMA Y; FONTANESI J; PORTER AT; WIERZBICKI JG; GASPAR L
      TREATING BRAIN CANCERS

      Science
    74. MARUYAMA Y; FONTANESI J; PORTER AT; WIERZBICKI JG; GASPAR L
      TREATING BRAIN CANCERS

      Science
    75. AHMAD K; PORTER AT
      TREATMENT OUTCOME IN HIGH-GRADE ASTROCYTOMA

      Clinical research
    76. DEVI SB; COURT WS; AREF AM; AHMAD K; PORTER AT
      TREATMENT OUTCOME IN ADVANCED HYPOPHARYNGEAL SQUAMOUS-CELL CARCINOMA

      Clinical research
    77. LIU B; MAHER RJ; HANNUN YA; PORTER AT; HONN KV
      12(S)-HETE ENHANCEMENT OF PROSTATE TUMOR-CELL INVASION - SELECTIVE ROLE OF PKC-ALPHA

      Journal of the National Cancer Institute
    78. ALEKHTEYAR KM; KIM EE; JANJAN NA; PORTER AT; TUCKER S
      DOES RADIOTHERAPY ALTER THE SIGNAL INTENSITY ON T2 WEIGHTED IMAGES INFOLLOW-UP MRI OF SOFT-TISSUE SARCOMAS

      International journal of radiation oncology, biology, physics
    79. PORTER AT; MCEWAN AJB; POWE JE; REID R; MCGOWAN DG; LUKKA H; SATHYANARAYANA JR; YAKEMCHUK VN; THOMAS GM; ERLICH LE; CROOK J; GULENCHYN KY; HONG KE; WESOLOWSKI C; YARDLEY J
      RESULTS OF A RANDOMIZED PHASE-III TRIAL TO EVALUATE THE EFFICACY OF SR-89 ADJUVANT TO LOCAL FIELD EXTERNAL BEAM IRRADIATION IN THE MANAGEMENT OF ENDOCRINE RESISTANT METASTATIC PROSTATE-CANCER

      International journal of radiation oncology, biology, physics
    80. PLUME CA; DALY SE; PORTER AT; BARNETT RB; BATTISTA JJ
      THE RELATIVE BIOLOGICAL EFFECTIVENESS OF YB-169 FOR LOW-DOSE RATE IRRADIATION OF CULTURED-MAMMALIAN-CELLS

      International journal of radiation oncology, biology, physics
    81. GARDE SV; SHETH AR; PORTER AT; PIENTA KJ
      A COMPARATIVE-STUDY ON EXPRESSION OF PROSTATIC INHIBIN PEPTIDE, PROSTATE ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN IN ANDROGEN-INDEPENDENT HUMAN AND RAT PROSTATE CARCINOMA CELL-LINES

      Cancer letters
    82. PORTER AT; KACZOR JG; FORMAN JD
      PERSPECTIVES ON THE ROLE OF RADIOTHERAPY IN ORGAN-CONFINED AND LOCALLY ADVANCED PROSTATE-CANCER

      European urology
    83. STUDER UE; WALTHER PJ; PORTER AT; BENSON RC
      WORKSHOP SUMMARY - APPROACHES TO RADICAL PROSTATECTOMY

      European urology
    84. MERTENS WC; STITT L; PORTER AT
      SR-89 THERAPY AND RELIEF OF PAIN IN PATIENTS WITH PROSTATIC-CARCINOMAMETASTATIC TO BONE - A DOSE-RESPONSE RELATIONSHIP

      American journal of clinical oncology
    85. FORMAN JD; OPPENHEIM T; LIU H; MONTIE J; MCLAUGHLIN PW; PORTER AT
      FREQUENCY OF RESIDUAL NEOPLASM IN THE PROSTATE FOLLOWING 3-DIMENSIONAL CONFORMAL RADIOTHERAPY

      The Prostate
    86. GARDE S; SHETH A; PORTER AT; PIENTA KJ
      EFFECT OF PROSTATIC INHIBIN PEPTIDE (PIP) ON PROSTATE-CANCER CELL-GROWTH INVITRO AND INVIVO

      The Prostate
    87. FORMAN JD; ORTON C; EZZELL G; PORTER AT
      PRELIMINARY-RESULTS OF A HYPERFRACTIONATED DOSE-ESCALATION STUDY FOR LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE

      Radiotherapy and oncology
    88. PORTER AT; CHISHOLM GD
      PALLIATION OF PAIN IN BONY METASTASES

      Seminars in oncology
    89. PORTER AT; MCEWAN AJB
      SR-89 AS AN ADJUVANT TO EXTERNAL-BEAM RADIATION IMPROVES PAIN RELIEF AND DELAYS DISEASE PROGRESSION IN ADVANCED PROSTATE-CANCER - RESULTS OF A RANDOMIZED CONTROLLED TRIAL

      Seminars in oncology
    90. FINOCCHIARO ML; CIANFLONE D; PORTER AT; LUPI A; CIANFRONE N; CREA F; MASERI A
      DIFFERENT RESPONSES TO INTRACORONARY ADENOSINE AND DIPYRIDAMOLE IN SYNDROME-X AND IN PATIENTS WITH STABLE ANGINA FOLLOWING SUCCESSFUL CORONARY ANGIOPLASTY

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 03:14:27